Abstract
Synchronizing rhythms of behaviour and metabolic processes is important for cardiovascular health and preventing metabolic diseases. The nuclear receptors REV-ERB-α and REV-ERB-β have an integral role in regulating the expression of core clock proteins driving rhythms in activity and metabolism. Here we describe the identification of potent synthetic REV-ERB agonists with in vivo activity. Administration of synthetic REV-ERB ligands alters circadian behaviour and the circadian pattern of core clock gene expression in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes in the liver, skeletal muscle and adipose tissue was also altered, resulting in increased energy expenditure. Treatment of diet-induced obese mice with a REV-ERB agonist decreased obesity by reducing fat mass and markedly improving dyslipidaemia and hyperglycaemia. These results indicate that synthetic REV-ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia
Journal of Experimental & Clinical Cancer Research Open Access 24 August 2023
-
Impact of the circadian nuclear receptor REV-ERBα in dorsal raphe 5-HT neurons on social interaction behavior, especially social preference
Experimental & Molecular Medicine Open Access 03 August 2023
-
Targeted screening and identification of chlorhexidine as a pro-myogenic circadian clock activator
Stem Cell Research & Therapy Open Access 31 July 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Welsh, D. K., Takahashi, J. S. & Kay, S. A. Suprachiasmatic nucleus: Cell autonomy and network properties. Annu. Rev. Physiol. 72, 551–577 (2010)
Bass, J. & Takahashi, J. S. Circadian integration of metabolism and energetics. Science 330, 1349–1354 (2010)
Ko, C. H. & Takahashi, J. S. Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 15, R271–R277 (2006)
Preitner, N. et al. The orphan nuclear receptor rev-erbα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110, 251–260 (2002)
Crumbley, C. & Burris, T. P. Direct regulation of CLOCK expression by REV-ERB. PLoS ONE 6, e17290 (2011)
Raghuram, S. et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ. Nature Struct. Mol. Biol. 14, 1207–1213 (2007)
Yin, L. et al. Rev-erbα, a heme sensor that coordinates metabolic and circadian pathways. Science 318, 1786–1789 (2007)
Kojetin, D., Wang, Y., Kamenecka, T. M. & Burris, T. P. Identification of sr8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem. Biol. 6, 131–134 (2011)
Kumar, N. et al. Regulation of adipogenesis by natural and synthetic REV-ERB ligands. Endocrinology 151, 3015–3025 (2010)
Grant, D. et al. Gsk4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. ACS Chem. Biol. 5, 925–932 (2010)
Meng, Q. J. et al. Ligand modulation of REV-ERBα function resets the peripheral circadian clock in a phasic manner. J. Cell Sci. 121, 3629–3635 (2008)
Kumar, N. et al. The benzenesulfoamide t0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-α/γ inverse agonist. Mol. Pharmacol. 77, 228–236 (2010)
Busby, S. A. et al. Identification of a novel non-retinoid pan inverse agonist of the retinoic acid receptors. ACS Chem. Biol. 6, 618–627 (2011)
Yoo, S. H. et al. Period2: Luciferase real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl Acad. Sci. USA 101, 5339–5346 (2004)
Wang, J., Yin, L. & Lazar, M. A. The orphan nuclear receptor Rev-erbα regulates circadian expression of plasminogen activator inhibitor type 1. J. Biol. Chem. 281, 33842–33848 (2006)
Le Martelot, G. et al. REV-ERBa participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol. 7, e1000181 (2009)
Duez, H. et al. Regulation of bile acid synthesis by the nuclear receptor Rev-erbα. Gastroenterology 135, 689–698 (2008)
Green, C. B., Takahashi, J. S. & Bass, J. The meter of metabolism. Cell 134, 728–742 (2008)
Ramakrishnan, S. N., Lau, P., Burke, L. J. & Muscat, G. E. O. Rev-erbβ regulates the expression of genes involved in lipid absorption in skeletal muscle cells—evidence for cross-talk between orphan nuclear receptors and myokines. J. Biol. Chem. 280, 8651–8659 (2005)
Raspe, E. et al. Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription. J. Lipid Res. 43, 2172–2179 (2002)
Ramsey, K. M. et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651–654 (2009)
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M. & Sassone-Corsi, P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324, 654–657 (2009)
Bray, M. S. & Young, M. E. Regulation of fatty acid metabolism by cell autonomous circadian clocks: time to fatten up on information? J. Biol. Chem. 286, 11883–11889 (2011)
Asher, G. & Schibler, U. Crosstalk between components of circadian and metabolic cycles in mammals. Cell Metab. 13, 125–137 (2011)
Gimble, J. M., Sutton, G. M., Bunnell, B. A., Ptitsyn, A. A. & Floyd, Z. E. Prospective influences of circadian clocks in adipose tissue and metabolism. Nature Rev. Endocrinol. 7, 98–107 (2011)
Duez, H. & Staels, B. Rev-erb-α: An integrator of circadian rhythms and metabolism. J. Appl. Physiol. 107, 1972–1980 (2009)
Burris, T. P. Nuclear hormone receptors for heme: REV-ERBα and REV-ERBβ are ligand-regulated components of the mammalian clock. Mol. Endocrinol. 22, 1509–1520 (2008)
Yin, L., Wu, N. & Lazar, M. A. Nuclear receptor Rev-erbα: a heme receptor that coordinates circadian rhythm and metabolism. Nucl. Recept. Signal. 8, e001 (2010)
Acknowledgements
This work was supported by National Institutes of Health Grants (DK080201, MH092769 and DK089984) and the Howard Hughes Medical Institute. L.A.S. is the recipient of an individual National Research Service Award (DK088499).
Author information
Authors and Affiliations
Contributions
T.P.B. conceived the project. R.N., Y.S. and T.M.K. synthesized and analysed the ligands. L.A.S., Y.W., S.B., D.J.K. and T.P.B. designed/analysed and/or performed the transfection and biochemical assays. D.J.K. and T.H. designed and performed the CD analysis. T.P.B., L.A.S. and A.A.B. designed, analysed and performed the metabolic studies. Y.W., T.P.B., S.B. and T.L designed/analysed and/or performed the circadian gene expression and behaviour analysis. J.L. performed gene expression analysis. S.-H.Y. and J.S.T. designed and performed the studies using the Per2-luc mouse tissues. M.D.C. performed the pharmacokinetic analysis. T.P.B. wrote the manuscript with input from all of the authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Methods with additional references and Supplementary Figures 1–15. (PDF 2542 kb)
Rights and permissions
About this article
Cite this article
Solt, L., Wang, Y., Banerjee, S. et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 485, 62–68 (2012). https://doi.org/10.1038/nature11030
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature11030
This article is cited by
-
Brain nuclear receptors and cardiovascular function
Cell & Bioscience (2023)
-
Targeted screening and identification of chlorhexidine as a pro-myogenic circadian clock activator
Stem Cell Research & Therapy (2023)
-
The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia
Journal of Experimental & Clinical Cancer Research (2023)
-
Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway
Cell Death & Disease (2023)
-
An electroaffinity labelling platform for chemoproteomic-based target identification
Nature Chemistry (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.